04/06/2010 - SPARK Ventures to realise its investment in Complinet  |  06/05/2010 - CNBC launches on Livestation  |  17/12/2009 - Livestation adds CNN International to its channel offering  |  IMImobile raises $13m of equity for expansion  |  18/09/2009 - Founders of SPARK Ventures’ portfolio company notonthehighstreet.com win ‘Entrepreneur of the Year'  |  28/08/2009 - SPARK Ventures realises its investment in Unanimis  |  19/06/2009 - Telecom Express and IMImobile join forces to launch IMEXmobile - Mobile Interaction Specialist

Biological therapies:

Celldex Therapeutics, Inc.

GlycArt AG

Glycoform

Haemostatix

Oxford BioMedica plc

Oxitec

Diagnostics & point-of-care:

IDG

Oxford Biosensors

Oxford Immunotec

Vivacta Limited

Disease Management & wellness:

Gemini Biomedical

Genosis plc

Instrumentation:

Teraview

IT in Healthcare:

Mirada Solutions

Medical Devices & Medical Technology:

(No investments to date)

Nanotechnology:

Oxonica plc

Pharmaceuticals and Speciality pharmaceuticals:

Allergy Therapeutics plc

Cyclacel Inc

Lectus Therapeutics

Medigene AG

Oxagen

PowerMed

Sterix

Vernalis plc

Xention

Telemedicine & e-Health:

(No investments to date)

 

Mirada Solutions Limited is a leading developer of software and analytical tools for medical imaging workstations. Mirada's unique products aid better detection, diagnosis and management of disease through the application of powerful image analysis tools to medical images.

Originally formed in 2000 when spin-out companies OXIVA and OMIA merged, Mirada was acquired by CTI Molecular Imaging Inc in August 2003 which was in time acquired by Siemens in 2005.